Impact of a novel molecular TB diagnostic system in patients at high risk of TB mortality in rural South Africa (Uchwepheshe): Study protocol for a cluster randomised trial

Trials

Volumn 14, Issue 1, 2013, Pages

  Lessells, Richard J ^a,b   Cooke, Graham S ^b,c   McGrath, Nuala ^b,d   Nicol, Mark P ^e   Newell, Marie Louise ^b,f   Godfrey Faussett, Peter ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b UNIVERSITY OF KWAZULU NATAL   (South Africa)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

^d UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^e UNIVERSITY OF CAPE TOWN   (South Africa)

^f UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Clinical trial; HIV; Molecular diagnostics; Multidrug resistant tuberculosis; Point of care systems; Tuberculosis

Indexed keywords

ADULT; ARTICLE; BINOMIAL DISTRIBUTION; CLUSTER ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; HEALTH CENTER; HIGH RISK PATIENT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LUNG TUBERCULOSIS; MOLECULAR DIAGNOSTICS; MORTALITY; MULTIDRUG RESISTANT TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; OUTCOME ASSESSMENT; RANDOMIZED CONTROLLED TRIAL; RURAL AREA; SOUTH AFRICA; SPUTUM CULTURE; TREATMENT DURATION; UNIVARIATE ANALYSIS;

AMBULATORY CARE FACILITIES; ANTITUBERCULAR AGENTS; BACTERIOLOGICAL TECHNIQUES; CLINICAL PROTOCOLS; COINFECTION; HIV INFECTIONS; HUMANS; LABORATORIES; LOGISTIC MODELS; MOLECULAR DIAGNOSTIC TECHNIQUES; MYCOBACTERIUM TUBERCULOSIS; POINT-OF-CARE SYSTEMS; PREDICTIVE VALUE OF TESTS; PRIMARY HEALTH CARE; RESEARCH DESIGN; RISK ASSESSMENT; RISK FACTORS; RURAL HEALTH SERVICES; SOUTH AFRICA; SPUTUM; TIME FACTORS; TUBERCULOSIS, MULTIDRUG-RESISTANT; TUBERCULOSIS, PULMONARY;

EID: 84878708464     PISSN: None     EISSN: 17456215     Source Type: Journal    
DOI: 10.1186/1745-6215-14-170     Document Type: Article

References (41)

1. Chaisson RE, Martinson NA. Tuberculosis in Africa-combating an HIV-driven crisis. N Engl J Med 2008, 358:1089-1092. 10.1056/NEJMp0800809, 18337598.
2. Abdool Karim SS, Churchyard GJ, Abdool Karim Q, Lawn SD. HIV infection and tuberculosis in South Africa: an urgent need to escalate the public health response. Lancet 2009, 374:921-933. 10.1016/S0140-6736(09)60916-8, 2803032, 19709731.
3. Gandhi NR, Nunn P, Dheda K, Schaaf HS, Zignol M, van Soolingen D, Jensen P, Bayona J. Multidrug-resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosis. Lancet 2010, 375:1830-1843. 10.1016/S0140-6736(10)60410-2, 20488523.
4. Stop TB Partnership, World Health Organization The global plan to stop TB, 2006-2015 2006, Geneva: World Health Organization, 3199789, 21835033, Stop TB Partnership, World Health Organization.
5. United Nations General Assembly Road map toward the implementation of the United Nations Millennium Declaration http://www.un.org/millenniumgoals/sgreport2001.pdf?OpenElement, United Nations General Assembly.
6. Parsons LM, Somoskovi A, Gutierrez C, Lee E, Paramasivan CN, Abimiku A, Spector S, Roscigno G, Nkengasong J. Laboratory diagnosis of tuberculosis in resource-poor countries: challenges and opportunities. Clin Microbiol Rev 2011, 24:314-350. 10.1128/CMR.00059-10, 3122496, 21482728.
7. Sreeramareddy CT, Panduru KV, Menten J, Van den Ende J. Time delays in diagnosis of pulmonary tuberculosis: a systematic review of literature. BMC Infect Dis 2009, 9:91. 10.1186/1471-2334-9-91, 2702369, 19519917.
8. Storla DG, Yimer S, Bjune GA. A systematic review of delay in the diagnosis and treatment of tuberculosis. BMC Publ Health 2008, 8:15.
9. Botha E, den Boon S, Lawrence KA, Reuter H, Verver S, Lombard CJ, Dye C, Enarson DA, Beyers N. From suspect to patient: tuberculosis diagnosis and treatment initiation in health facilities in South Africa. Int J Tuberc Lung Dis 2008, 12:936-941.
10. Botha E, Den Boon S, Verver S, Dunbar R, Lawrence KA, Bosman M, Enarson DA, Toms I, Beyers N. Initial default from tuberculosis treatment: how often does it happen and what are the reasons?. Int J Tuberc Lung Dis 2008, 12:820-823.
11. Creek TL, Lockman S, Kenyon TA, Makhoa M, Chimidza N, Moeti T, Sarpong BB, Binkin NJ, Tappero JW. Completeness and timeliness of treatment initiation after laboratory diagnosis of tuberculosis in Gaborone, Botswana. Int J Tuberc Lung Dis 2000, 4:956-961.
12. Nyirenda T, Harries AD, Banerjee A, Salaniponi FM. Registration and treatment of patients with smear-positive pulmonary tuberculosis. Int J Tuberc Lung Dis 1998, 2:944-945.
13. Squire SB, Belaye AK, Kashoti A, Salaniponi FM, Mundy CJ, Theobald S, Kemp J. 'Lost' smear-positive pulmonary tuberculosis cases: where are they and why did we lose them?. Int J Tuberc Lung Dis 2005, 9:25-31.
14. Gandhi NR, Shah NS, Andrews JR, Vella V, Moll AP, Scott M, Weissman D, Marra C, Lalloo UG, Friedland GH. HIV coinfection in multidrug- and extensively drug-resistant tuberculosis results in high early mortality. Am J Respir Crit Care Med 2010, 181:80-86. 10.1164/rccm.200907-0989OC, 19833824.
15. Heller T, Lessells RJ, Wallrauch CG, Barnighausen T, Cooke GS, Mhlongo L, Master I, Newell ML. Community-based treatment for multidrug-resistant tuberculosis in rural KwaZulu-Natal, South Africa. Int J Tuberc Lung Dis 2010, 14:420-426.
16. Helb D, Jones M, Story E, Boehme C, Wallace E, Ho K, Kop J, Owens MR, Rodgers R, Banada P, et al. Rapid detection of Mycobacterium tuberculosis and rifampin resistance by use of on-demand, near-patient technology. J Clin Microbiol 2010, 48:229-237. 10.1128/JCM.01463-09, 2812290, 19864480.
17. Boehme CC, Nabeta P, Hillemann D, Nicol MP, Shenai S, Krapp F, Allen J, Tahirli R, Blakemore R, Rustomjee R, et al. Rapid molecular detection of tuberculosis and rifampin resistance. N Engl J Med 2010, 363:1005-1015. 10.1056/NEJMoa0907847, 2947799, 20825313.
18. Boehme CC, Nicol MP, Nabeta P, Michael JS, Gotuzzo E, Tahirli R, Gler MT, Blakemore R, Worodria W, Gray C, et al. Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study. Lancet 2011, 377:1495-1505. 10.1016/S0140-6736(11)60438-8, 3085933, 21507477.
19. World Health Organization Policy statement: automated real-time nucleic acid amplification technology for rapid and simultaneous detection of tuberculosis and rifampicin resistance: Xpert MTB/RIF system 2011, Geneva: World Health Organization, World Health Organization.
20. World Health Organization Rapid implementation of the Xpert MTB/RIF diagnostic test: technical and operational 'How-to'; practical considerations 2011, Geneva: World Health Organization, World Health Organization.
21. Weyer K, Mirzayev F, Migliori G, Van Gemert W, D'Ambrosio L, Zignol M, Floyd K, Centis R, Cirillo D, Tortoli E, et al. Rapid molecular TB diagnosis: evidence, policy-making and global implementation of Xpert(R)MTB/RIF. Eur Respir J 2012, [Epub ahead of print].
22. Wallrauch C, Heller T, Lessells R, Kekana M, Barnighausen T, Newell ML. High uptake of HIV testing for tuberculosis patients in an integrated primary health care HIV/TB programme in rural KwaZulu-Natal. S Afr Med J 2010, 100:146-147.
23. Herbst AJ, Cooke GS, Barnighausen T, KanyKany A, Tanser F, Newell ML. Adult mortality and antiretroviral treatment roll-out in rural KwaZulu-Natal, South Africa. Bull World Health Organ 2009, 87:754-762. 10.2471/BLT.08.058982, 2755311, 19876542.
24. World Health Organization Guidelines for the programmatic management of drug-resistant tuberculosis: emergency update 2008 2008, Geneva: World Health Organization, World Health Organization.
25. Department of Health RoSA National Tuberculosis Management Guidelines 2009, Pretoria: Department of Health, Department of Health RoSA.
26. Hayes RJ, Bennett S. Simple sample size calculation for cluster-randomized trials. Int J Epidemiol 1999, 28:319-326. 10.1093/ije/28.2.319, 10342698.
27. Department of Health RoSA Management of drug-resistant tuberculosis: Policy guidelines 2011, Pretoria: Department of Health, Department of Health RoSA.
28. Hayes RJ, Moulton LH. Cluster randomised trials 2009, Boca Raton, Florida: Chapman & Hall/CRC.
29. Glidden DV, Vittinghoff E. Modelling clustered survival data from multicentre clinical trials. Stat Med 2004, 23:369-388. 10.1002/sim.1599, 14748034.
30. Lessells RJ, Cooke GS, Newell ML, Godfrey-Faussett P. Evaluation of tuberculosis diagnostics: establishing an evidence base around the public health impact. J Infect Dis 2011, 204(Suppl 4):S1187-S1195. 10.1093/infdis/jir412, 3192544, 21996701.
31. Bagchi AD, Dale S, Verbitsky-Savitz N, Andrecheck S, Zavotsky K, Eisenstein R. Examining effectiveness of medical interpreters in emergency departments for Spanish-speaking patients with limited English proficiency: results of a randomized controlled trial. Ann Emerg Med 2011, 57:248-256. e241-244, 10.1016/j.annemergmed.2010.05.032, 20678825.
32. Loten C, Attia J, Hullick C, Marley J, McElduff P. Validation of a point of care troponin assay in real life Emergency Department conditions. Emerg Med Australas 2009, 21:286-292. 10.1111/j.1742-6723.2009.01198.x, 19682013.
33. Zwarenstein MF, Dainty KN, Quan S, Kiss A, Adhikari NK. A cluster randomized trial evaluating electronic prescribing in an ambulatory care setting. Trials 2007, 8:28. 10.1186/1745-6215-8-28, 2092426, 17915028.
34. Hall S, Reid E, Ukoumunne OC, Weinman J, Marteau TM. Brief smoking cessation advice from practice nurses during routine cervical smear tests appointments: a cluster randomised controlled trial assessing feasibility, acceptability and potential effectiveness. Br J Cancer 2007, 96:1057-1061. 10.1038/sj.bjc.6603684, 2360134, 17406348.
35. Kunkler IH, Prescott RJ, Lee RJ, Brebner JA, Cairns JA, Fielding RG, Bowman A, Neades G, Walls AD, Chetty U, et al. TELEMAM: a cluster randomised trial to assess the use of telemedicine in multi-disciplinary breast cancer decision making. Eur J Cancer 2007, 43:2506-2514. 10.1016/j.ejca.2007.08.026, 17962011.
36. Wallengren K, Scano F, Nunn P, Margot B, Buthelezi SS, Williams B, Pym A, Samuel EY, Mirzayev F, Nkhoma W, et al. Drug-resistant tuberculosis, KwaZulu-Natal, South Africa, 2001-2007. Emerg Infect Dis 2011, 17:1913-1916. 10.3201/eid1710.100952, 3310642, 22000370.
37. Xpert Research Mapping Project [http://xrmt.treattb.org/], Xpert Research Mapping Project.
38. Clouse K, Page-Shipp L, Dansey H, Moatlhodi B, Scott L, Bassett J, Stevens W, Sanne I, Van Rie A. Implementation of Xpert MTB/RIF for routine point-of-care diagnosis of tuberculosis at the primary care level. S Afr Med J 2012, 102:805-807.
39. Van Rie A, Page-Shipp L, Hanrahan CF, Schnippel K, Dansey H, Bassett J, Clouse K, Scott L, Stevens W, Sanne I. Point-of-care Xpert MTB/RIF for smear-negative tuberculosis suspects at a primary care clinic in South Africa. Int J Tuberc Lung Dis 2013, 17:368-372. 10.5588/ijtld.12.0392, 23407225.
40. Batz HG, Cooke GS, Reid SD. Towards lab-free tuberculosis diagnosis http://www.msfaccess.org/sites/default/files/MSF_assets/TB/Docs/TB_Report_TowardsLabFreeTBDX_2011_ENG.pdf.
41. Dheda K, Ruhwald M, Theron G, Peter J, Yam WC. Point-of-care diagnosis of tuberculosis: past, present and future. Respirology 2013, 18:217-232. 10.1111/resp.12022, 23190246.